Medicine and Dentistry
Patient
100%
Esophageal Adenocarcinoma
71%
Positron Emission Tomography-Computed Tomography
67%
Endoscopic Ultrasound
67%
Adenocarcinoma
46%
Lymph Node
44%
Cohort Analysis
39%
Esophageal Cancer
37%
Neoadjuvant Chemotherapy
37%
Prognosis
33%
Tumor Regression
33%
Computer Assisted Tomography
33%
Cancer Surgery
33%
Dysplasia
33%
Retroperitoneal Lymph Node Dissection
33%
Neoadjuvant Therapy
33%
Overall Survival
31%
Hazard Ratio
27%
Esophagectomy
26%
Endoscopic Mucosal Resection
16%
Esophagus
13%
Association
11%
Age
9%
Disease
8%
Endoscopic Therapy
8%
Neoplasm
8%
Histology
8%
Follow up
5%
Proportional Hazards Model
5%
Clinical Guideline
5%
Dose Response
5%
Hospital
5%
Tumor Differentiation
5%
Preoperative Chemotherapy
5%
Biochemistry, Genetics and Molecular Biology
Esophagus
33%
Methylation
26%
Epigenetics
7%
Gene
7%
Genomics
7%
